Morning Overview on MSN
Biotech uses Apple Watch data to track Parkinson’s drug effects in trial
BlueRock Therapeutics, a Bayer subsidiary developing stem cell treatments for Parkinson’s disease, has partnered with Rune ...
After 30 months of fast-paced innovation in quantum algorithms, six research groups are hoping to hit paydirt. But there can ...
High blood pressure, also known as hypertension, is one of the most common health problems in the world. It affects nearly half of adults in the United States and many millions more worldwide. Often ...
But buried beneath the vendor / agency drama is a structural truth every CMO needs to understand: we've entered an era where you must differentiate between Fee Collectors and Tax Collectors. The ...
The ANVS-25002 study is expected to enroll approximately 500 participants with Parkinson’s disease across multiple clinical ...
A blood pressure program adopted across the University of California's six academic medical centers has effectively lowered ...
Dozens of companies now claim AI capabilities, but few can point to clinical evidence that their technology changes health outcomes. Last week, Carrot brought that evidence to a national stage. Carrot ...
The new program is supposed to save taxpayer dollars. Doctors and patients in Washington say that it's disrupting and delaying medical care.
Medical Device Network on MSN
Sacral neuromodulation: broadening Boston Scientific’s European urology portfolio
Boston Scientific added SNM to its urology portfolio following its 2024 acquisition of Axonics.
As measles cases rise across the United States, clinical leaders must ensure their organizations have the clinical protocols, workforce training, and infection-control infrastructure needed to rapidly ...
This week, Bobbi Conner talks with MUSC's Dr. Andrea Abbott about right-sizing, or tailoring breast cancer treatment to the individual patient.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results